ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02891824
Brief Title: ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab (ATALANTE)

First Submitted : May 25, 2016
First Submitted that Met QC Criteria : September 7, 2016
First Posted : September 8, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : November 12, 2018
Last Update Posted : November 14, 2018